Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Adenoviridae Infections 1

Interventions

pembrolizumab 1 liposomal doxorubicin 1 atezolizumab 1 Tumor Necrosis Factor-alpha 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoviridae Infections × Tumor Necrosis Factor-alpha × 90 days × Clear all

NCT04695327 2026-03-06

TUNIMO

TILT Biotherapeutics Ltd.

Phase 1 Completed

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡